Can precision cancer treatment improve outcomes?

Advanced stage cancer patients provided with personalized treatments based on their tumor’s molecular information were more likely to survive or experience a longer period without disease progression. Advanced cancer patients being treated at the Moores Cancer Center at UC San Diego Health (CA, USA) were more likely to survive or experience a longer period without disease progression if they received precision cancer treatment. In order to initiate the study, which was published recently in Nature Communications, a molecular tumor advisory board was established comprised of experts in basic, translational and clinical research across multiple disciplines. They used information from patients’...